Ignite Creation Date:
2025-12-24 @ 11:41 PM
Ignite Modification Date:
2025-12-30 @ 4:05 PM
Study NCT ID:
NCT04316351
Status:
UNKNOWN
Last Update Posted:
2020-07-23
First Post:
2020-03-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Toripalimab (JS001) Combined With Pemetrexed and Anlotinib for Patients With T790M Positive Non-Small Cell Lung Cancer After Osimertinib Resistance
Sponsor:
Guangzhou Institute of Respiratory Disease
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-04-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-04-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-04-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-03-19
First Submit QC Date:
None
Study First Post Date:
2020-03-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-22
Last Update Post Date:
2020-07-23
Last Update Post Date Type:
ACTUAL